Major shareholder announcement
Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,646,085 shares of a nominal value of DKK 31,292,170, equivalent to 4.99% of Novozymes A/S' share capital and 1.96% of the voting rights.
Vedhæftede filer:
2016_14_Major Shareholder Announcement_EN.pdf
Udgivet af: NPinvestordk